Regulatory science provides the Medicines Evaluation Board with up-to-date data, knowledge and expertise based on current scientific insights, for optimal evaluation and marketing authorization of medicinal products and novel foods. This ensures an even better evaluation of risks, efficacy and quality. Visit the database with research themes which contains results and discover which research programmes the MEB supports.
opens the door to optimal evaluation
Early market access procedures are not associated with a higher probability of warnings as... | Arnardóttir, Arna H
Sponsors should engage in dialogue with the FDA and thoughtfully design pivotal clinical trials... | Heemstra, Harald